In the context of the present Application, a further development of the experimental animal model described in said paper serves for determining novel endogenous sepsis-specific biomarkers of a peptide or protein nature, the occurrence of which is characteristic of sepsis or certain forms of sepsis and which therefore permit a specific sepsis diagnosis.